Compare Himalaya Energi Perkasa Tbk. (HADE) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Himalaya Energi Perkasa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Himalaya Energi Perkasa Tbk. trades at Rp24 (market cap 55.12B, 24.26M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| HADE | SCPI | |
|---|---|---|
Market Cap | 55.12B | 104.4B |
Volume | 24.26M | — |
Lot | 242.63K | — |
Turnover | 590.77M | — |
Average Price | 24.35 | — |
Value | 590.77M | — |
Indicative Equilibrium Price | 24 | — |
Indicative Equilibrium Volume | 69.02K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Himalaya Energi Perkasa Tbk.
PT HD Capital Tbk formerly PT Hortus Danavest Tbk. (the Company) was established under the name of PT Harumdana Sekuritas based on the Notarial Deed No. 24 dated February 10th, 1989 of Soebagjo Ronoatmodjo S.H., notary in Jakarta. The Company divides business into 3 divisions, Stock Brokerage & Trading Division, Corporate Finance & Investment Banking and Fixed Income Division. The Company is member of Jakarta Stock Exchange and Surabaya Stock Exchange.
Read more on HADE →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
